Factors influencing dosing and concentrations of sirolimus in de novo heart transplant recipients.

被引:0
|
作者
Akhlaghi, F
Zahir, H
Keogh, AM
机构
[1] Univ Rhode Isl, Kingston, RI 02881 USA
[2] St Vincents Hosp, Heart Lung Transplant Unit, Sydney, NSW 2010, Australia
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
049
引用
收藏
页码:169 / 169
页数:1
相关论文
共 50 条
  • [41] CARDIOVASCULAR EVENTS WITH DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS
    Potena, Luciano
    Schulz, Uwe
    Bara, Christoph
    Arizon Del Prado, Jose M.
    Balfour, Alison
    Kohler, Sven
    Lopez, Patricia M.
    Epailly, Eric
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 46 - 46
  • [42] Sirolimus and Tacrolimus Dosing Requirements in Pediatric Heart Transplant Recipients to Target Combined Trough Levels
    Jarosz, A.
    Zamberlan, M.
    Owns, G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S497 - S498
  • [43] De novo cancer in transplant recipients
    Kim, MS
    Kim, SI
    Kim, YS
    Oh, CK
    Park, K
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1651 - 1652
  • [44] De novo calcineurin-inhibitor-free/sirolimus-based immunosuppression in pediatric heart transplant recipients with renal failure
    Fenton, M. J.
    Burch, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S86 - S86
  • [45] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients.
    Keown, P
    Ethgen, O
    Yang, XL
    Ricci, JF
    Kessabi, S
    Spaepen, S
    Annemans, L
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 504 - 504
  • [46] Eplet Mismatches and De Novo Donor Surface Antibody Development in Pediatric Renal Transplant Recipients.
    Blanchette, E.
    Bradford, M.
    Warner, P.
    Blosser, C.
    Gimferrer, I.
    Smith, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 266 - 267
  • [47] A POTENTIAL FOR INDIVIDUALIZED DOSING OF PREDNISOLONE IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.
    Skauby, R. K. H.
    Bjerre, A. K.
    Saeves, I.
    Svarstad, A.
    Bremer, S.
    Bergan, S.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 36 - 36
  • [48] Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V.
    Shaffer, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 544 - 544
  • [49] Elevated De Novo Donor Specific Antibody After Alemtuzumab Induction in Renal Transplant Recipients.
    Fabbri, K.
    Descourouez, J.
    Jorgenson, M.
    Redfield, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 619 - 619
  • [50] Evaluation of Voriconazole Dosing for Preventing Aspergillus in Lung Transplant Recipients.
    Chaplain, A.
    Pierce, B. J.
    Pham, C.
    Hutchins, A.
    Musick, W. L.
    Nguyen, D. T.
    Graviss, E. A.
    Yau, S. W.
    Youssef, J. G.
    Goodarzi, A.
    Huang, H. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 988 - 989